(RTTNews) - Shares of online personal styling service, Stitch Fix, Inc. (SFIX) are down more than 9% Wednesday morning on wider than expected fourth-quarter loss.
SPECIAL ALERT: The upcoming election could spark a major buying opportunity for savvy investors. Both President Trump and Joe Biden have announced big plans that could move trillions into new market sectors. Those sectors could surge higher immediately after the election in an
The COVID-19 crisis has been downright awful for the entire financial sector. Banks have been sold based on fears of rising consumer and corporate delinquencies. The big provisions for loan losses have been taken, but so far we haven't seen the big writedowns of assets. The bank
As of Sept. 21, the major indices have been on their third consecutive week of losses, with the tech-heavy Nasdaq 100 down nearly 13% from its peak. There are many reasons for this sudden correction, including excessive buying of call options on tech stocks, uncertainty surround
In this episode of Industry Focus: Tech, Dylan Lewis chats with Motley Fool analyst Brian Feroldi about one of the most recent SaaS companies to go public. JFrog (NASDAQ: FROG) is a pioneer and leader in the space it operates in, and the guys explain the value proposition behind
Corsair Gaming, which designs and supplies personal computer and gaming hardware components, raised $238 million by offering 14 million shares (54% primary) at $17, within the range of $16 to $18.
Corsair Gaming plans to list on the Nasdaq under the symbol CRSR. Goldman Sachs, Ba
After all of these months of tracking coronavirus vaccine developers' progress, we're nearing the final stages of the race. As of today, nine programs are in phase 3 studies. And a vaccine may come even before the completion of that stage. U.S. Food and Drug Administration Commi
(RTTNews) - Johnson & Johnson (JNJ) announced Wednesday the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.
Biotech companies working on vaccines or treatments for COVID-19 have been grabbing much attention from pundits and analysts. But for investors, it's important to remember that there are companies within this industry that are not directly involved in the fight against the coron
This year will be remembered for lots of things. The COVID-19 pandemic, of course. The wild stock market roller coaster ride. The most named tropical storms in history.
This has been a wild year to be an investor. We've witnessed some of the craziest up-and-down vacillations in the history of the stock market, and yet the S&P 500 sits pretty darn close to the flat line on a year-to-date basis.
Shares of Snowflake (NYSE: SNOW) recently debuted with a bang, closing its first day of trading 111% higher than its initial public offering price of $120 per share, and raising about $3.4 billion in the largest software IPO ever. For many institutional investors, such as hedge
Social Security benefits are vital for millions of older Americans, with 64% of current retirees saying their benefits are a major source of income, according to a report from the Society of Actuaries.
Some investors apparently thought that Aurora Cannabis (NYSE: ACB) would report some good news in its results for the fourth quarter of fiscal 2020 ended June 30, 2020. Shares of the Canadian cannabis producer jumped nearly 16% on Tuesday ahead of the company's Q4 update.
Few companies have gone from almost complete anonymity among retail investors to huge buzz like Snowflake (NYSE: SNOW) has over the past couple of months. With the incredible run cloud computing stocks have had this year, interest in Snowflake exploded as investors chased the n